Ptc Therapeutics (PTCT) Finished Goods (2019 - 2026)

Ptc Therapeutics' Finished Goods history runs 8 years deep, the most recent figure standing at $21.2 million for Q1 2026.

• In Q1 2026, Finished Goods rose 225.27% year-over-year to $21.2 million; the TTM figure through Mar 2026 stood at $21.2 million (up 225.27% YoY), while the FY2025 annual figure was $21.7 million, up 156.75% from the prior year.
• Finished Goods was $21.2 million for Q1 2026 at Ptc Therapeutics, down from $21.7 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $21.7 million in Q4 2025 to a low of $5.7 million in Q1 2022.
• Historically, Finished Goods has averaged $9.4 million across 5 years, with a median of $7.5 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Finished Goods sank 33.45% in 2024, then jumped 225.27% in 2026.
• A 5-year view of Finished Goods shows it stood at $6.7 million in 2022, then jumped by 74.79% to $11.6 million in 2023, then fell by 27.45% to $8.4 million in 2024, then surged by 156.75% to $21.7 million in 2025, then slipped by 2.33% to $21.2 million in 2026.
• The last three Finished Goods figures came in at $21.2 million (Q1 2026), $21.7 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.